Dendritic Cell Maturation and Activation and Pancreatic Ribonuclease, Induce Members, Eosinophil-Derived Neurotoxin Human Ribonuclease A Superfamily

A number of mammalian antimicrobial proteins produced by neutrophils and cells of epithelial origin have chemotactic and activating effects on host cells, including cells of the immune system. Eosinophil granules contain an antimicrobial protein known as eosinophil-derived neurotoxin (EDN), which belongs to the RNase A superfamily. EDN has antiviral and chemotactic activities in vitro. In this study, we show that EDN, and to a lesser extent human pancreatic RNase (hPR), another RNase A superfamily member, activates human dendritic cells (DCs), leading to the production of a variety of inflammatory cytokines, chemokines, growth factors, and soluble receptors. Human angiogenin, a RNase evolutionarily more distant to EDN and hPR, did not display such activating effects. Additionally, EDN and hPR also induced phenotypic and functional maturation DCs. These RNases were as efficacious as TNF- (cid:1) , but induced a different set of cytokine mediators. Furthermore, EDN production by human macrophages could be induced by proinflammatory stimuli. The results reveal the DC-activating activity of EDN and hPR and suggest that they are likely participants of inflammatory and immune responses. A number of endogenous mediators in addition to EDN have been reported to have both chemotactic and activating

[1]  K. Dyer,et al.  Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. , 2003, Blood.

[2]  Robert E. Lewis,et al.  Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells. , 2003, Experimental and molecular pathology.

[3]  S. Rybak,et al.  Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition , 2003, AIDS.

[4]  S. Kingsmore,et al.  Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. , 2003, Current opinion in biotechnology.

[5]  K. Tracey,et al.  HMGB1 as a DNA‐binding cytokine , 2002, Journal of leukocyte biology.

[6]  M. Goldman,et al.  Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns , 2002, European journal of immunology.

[7]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[8]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[9]  David C. H. Yang,et al.  Histidyl–tRNA Synthetase and Asparaginyl–tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells , 2002, The Journal of experimental medicine.

[10]  G. Fedele,et al.  Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. , 2002, The Journal of infectious diseases.

[11]  J. Olivot,et al.  Human endothelial cells selectively express large amounts of pancreatic‐type ribonuclease (RNase 1) , 2002, Journal of cellular biochemistry.

[12]  K. Iwabuchi,et al.  A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis , 2002, Immunology.

[13]  S. Kingsmore,et al.  Multiplexed protein profiling on microarrays by rolling-circle amplification , 2002, Nature Biotechnology.

[14]  K. Iwabuchi,et al.  Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. , 2002, International immunology.

[15]  Ji Ming Wang,et al.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[17]  H. Nishiura,et al.  Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer. , 2001, The American journal of pathology.

[18]  L. Kwak,et al.  Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens , 2001, The Journal of Immunology.

[19]  K. Tokunaga,et al.  Gene Expression Analysis in Human Monocytes, Monocyte-Derived Dendritic Cells, and α-Galactosylceramide-Pulsed Monocyte- Derived Dendritic Cells , 2001 .

[20]  H. Rosenberg,et al.  Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens , 2001, Journal of leukocyte biology.

[21]  Rainer Hedrich,et al.  Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity , 2001, Cell and Tissue Research.

[22]  Y. Liu,et al.  Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.

[23]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  O. Chertov,et al.  The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity , 2001, Cellular and Molecular Life Sciences CMLS.

[25]  I. Nagaoka,et al.  Evaluation of the effects of peptide antibiotics human β‐defensins‐1/‐2 and LL‐37 on histamine release and prostaglandin D2 production from mast cells , 2001 .

[26]  Ji Ming Wang,et al.  Differential Regulation of Formyl Peptide Receptor-Like 1 Expression During the Differentiation of Monocytes to Dendritic Cells and Macrophages1 , 2001, The Journal of Immunology.

[27]  G. Walsh Eosinophil granule proteins and their role in disease , 2001, Current opinion in hematology.

[28]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[29]  S. Stoll,et al.  Differential Regulation of Responsiveness to fMLP and C5a Upon Dendritic Cell Maturation: Correlation with Receptor Expression1 2 , 2000, The Journal of Immunology.

[30]  O. Chertov,et al.  Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells , 2000, Journal of leukocyte biology.

[31]  D. Newton,et al.  Natural and engineered cytotoxic ribonucleases: therapeutic potential. , 1999, Experimental cell research.

[32]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[33]  P. Allavena,et al.  The role of chemokines in the regulation of dendritic cell trafficking , 1999, Journal of leukocyte biology.

[34]  P. Schimmel,et al.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.

[35]  V. Kindler,et al.  Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. , 1999, Blood.

[36]  F. Blasi The urokinase receptor. A cell surface, regulated chemokine , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[37]  H. Kita,et al.  Localization of Eosinophil–Derived Neurotoxin and Eosinophil Cationic Protein in Neutrophilic Leukocytes , 1999, International Archives of Allergy and Immunology.

[38]  J. Lillard,et al.  Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Newton,et al.  Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth. , 1998, Journal of the National Cancer Institute.

[40]  S. Sorrentino Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types , 1998, Cellular and Molecular Life Sciences CMLS.

[41]  K. Dyer,et al.  Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. , 1998, The Journal of infectious diseases.

[42]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[43]  K. Dyer,et al.  Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. , 1997, Biochimica et biophysica acta.

[44]  D. Newton,et al.  Cloning and cytotoxicity of a human pancreatic RNase immunofusion. , 1997, Immunotechnology : an international journal of immunological engineering.

[45]  P. Hiemstra,et al.  Effect of defensins on interleukin-8 synthesis in airway epithelial cells. , 1997, The American journal of physiology.

[46]  D. Newton,et al.  X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 A resolution. , 1996, Journal of molecular biology.

[47]  D. Taub,et al.  Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils (*) , 1996, The Journal of Biological Chemistry.

[48]  D. Newton,et al.  Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. , 1994, The Journal of biological chemistry.

[49]  D. Newton,et al.  Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo. , 1992, The Journal of biological chemistry.

[50]  D. Tenen,et al.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Durack,et al.  Purification of human eosinophil-derived neurotoxin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Rosenberg,et al.  Eosinophil-derived neurotoxin. , 2001, Methods in enzymology.

[53]  D. Newton,et al.  Antibody-Enzyme Fusions , 2001 .

[54]  R. Hancock,et al.  Cationic antimicrobial peptides and their multifunctional role in the immune system. , 2000, Critical reviews in immunology.